A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2011
08/30/2011	US8008027 Methods of screening for compounds that modulate the activity of ADEC, a chemokine expressed in inflamed adenoid
08/30/2011	US8007817 Compositions and methods for treating microbial infections
08/30/2011	US8007799 Vascular endothelial cell growth factor antagonists and uses thereof
08/30/2011	CA2645294C Dibenzyl amine compounds and derivatives
08/30/2011	CA2542813C Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromen-6-yl-derivatives, process and drugs containing these compounds
08/30/2011	CA2479665C Nanoparticulate compositions of angiogenesis inhibitors
08/30/2011	CA2458172C Coated medical devices
08/30/2011	CA2440473C Metalloproteinase inhibitors
08/30/2011	CA2436407C Polymer conjugates of neublastin and methods of using same
08/30/2011	CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
08/30/2011	CA2393352C Adamantane derivatives
08/30/2011	CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines
08/30/2011	CA2331329C Diacylglycerol acyl transferase proteins
08/25/2011	WO2011103382A2 Compositions and methods for inducing angiogenesis
08/25/2011	WO2011103330A2 Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury
08/25/2011	WO2011103128A1 Treatment of metabolic syndrome with novel amines
08/25/2011	WO2011103126A1 Treatment of metabolic syndrome with piperidine amides
08/25/2011	WO2011102695A2 Composition for preventing or treating diseases caused by over-expression of lxrα, containing liquiritigenin or isoliquiritigenin as active ingredient
08/25/2011	WO2011102574A1 Pharmaceutical composition for healing wounds, containing mic-1 gene or expression protein thereof
08/25/2011	WO2011102483A1 HUMAN LAP TGF-β BINDING ANTIBODY
08/25/2011	WO2011102436A1 Tgf-β signal transduction inhibitor
08/25/2011	WO2011102404A1 Imidazole derivative
08/25/2011	WO2011101644A1 Triazolo [4, 5 - b] pyridin derivatives
08/25/2011	WO2011101558A1 Novel method for synthesizing ivabradine and the pharmaceutically acceptable acid addition salts thereof
08/25/2011	WO2011101424A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
08/25/2011	WO2011101373A1 A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (prl)-growth hormone (gh)-placental lactogen (pl)-family protein
08/25/2011	WO2011080269A3 Pharmaceutical preparations comprising a cos releasing compound
08/25/2011	WO2011027971A3 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using same
08/25/2011	US20110208162 Methods for preventing aggregation of adipose stromal cells
08/25/2011	US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
08/25/2011	US20110207821 Method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis
08/25/2011	US20110207815 Tetrahydronaphthalene compounds
08/25/2011	US20110207811 Use of celivarone for reducing occurrences of cardiovascular hospitalization
08/25/2011	US20110207810 N1-benzo[1,3]dioxol-5-ylmethyl-n2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing same
08/25/2011	US20110207808 Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
08/25/2011	US20110207797 Enhanced antisense oligonucleotides
08/25/2011	US20110207791 Composition of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto
08/25/2011	US20110207785 2-Aryl-Propionic Acids and Derivatives and Pharmaceutical Compositions Containing Them
08/25/2011	US20110207783 Renin inhibitors
08/25/2011	US20110207773 Novel phenyl-quinoline-carboxylic acid pyridine derivatives useful as modulators of nicotinic acetylcholine receptors
08/25/2011	US20110207764 Cyclopolysaccharide compositions
08/25/2011	US20110207763 8-carboxamido-2,6-methano-3-benzazocines
08/25/2011	US20110207759 Method for treatment of atherosclerotic disease
08/25/2011	US20110207750 Benzimidazole and aza-benzimidazole carboxamides
08/25/2011	US20110207746 New compounds i
08/25/2011	US20110207742 Method for reduction, stabilization and prevention of rupture of lipid rich plaque
08/25/2011	US20110207741 Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death
08/25/2011	US20110207737 Substituted bicyclic amines for the treatment of diabetes
08/25/2011	US20110207734 Azine Derivatives and Methods of Use Thereof
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110207724 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anit-hypertensive compounds
08/25/2011	US20110207720 Quinolin-4-one and 4-oxodihyrdocinnoline derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
08/25/2011	US20110207714 Serotonin receptor modulators
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207710 Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase a2 (spla2) inhibitors and spla2 inhibitor combination therapies
08/25/2011	US20110207698 Heteroaryl-substituted dicyanopyridines and their use
08/25/2011	US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
08/25/2011	US20110207663 Fibroblast growth factor (fgf) analogs and uses thereof
08/25/2011	US20110207224 In vivo production of small interfering rnas that mediate gene silencing
08/25/2011	US20110206786 Acai and Iridoid Based Formulations
08/25/2011	US20110206761 Stable dosage forms of antihypertensive agents
08/25/2011	US20110206760 Angiopoietin derived peptides
08/25/2011	US20110206741 DHA Triglyceride Emulsions
08/25/2011	US20110206722 Pharmaceutical Composition For Purifying Blood Vessels And Preparation Method Thereof
08/25/2011	US20110206688 Enhancing Vessel Lesion Homing and Repair Potential of Stem Cells
08/25/2011	US20110206667 Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment
08/25/2011	US20110206653 Tetrazole compounds for reducing uric acid
08/25/2011	US20110206652 Methods for treating atherosclerosis
08/25/2011	US20110206647 Modulation of Angiogenesis
08/25/2011	US20110206646 Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
08/25/2011	US20110206644 Methods for trans-differentiating cells
08/25/2011	US20110206642 Preventing obesity-related metabolic syndrome with melagonesis
08/25/2011	US20110206633 Polymer conjugates of cd-np peptides
08/25/2011	US20110206612 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor
08/25/2011	US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011	DE102011009719A1 Agent useful e.g. for treating neurodermitis and diabetes mellitus comprises a fat phase including tocotrienols with lipids e.g. gamma -linolenic acid and an aqueous phase comprising e.g. palm fruit water, vitamin C, vitamin B2 and
08/25/2011	DE102010008982A1 Siliciumhaltiges, biologisch degradierbares Material zur anti-inflammatorischen Therapie A silicon-containing biologically degradable material for anti-inflammatory therapy
08/25/2011	DE102010008981A1 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie A silicon-containing biologically degradable material for pro-angiogenic therapy
08/25/2011	CA2790643A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
08/25/2011	CA2790176A1 Triazolo [4, 5 - b] pyridin derivatives
08/25/2011	CA2789259A1 Compositions and methods to treat cardiac diseases
08/24/2011	EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011	EP2360251A2 In vivo production of small interfering RNAs that mediate gene silencing
08/24/2011	EP2360242A1 Method of enhancing proliferation and/or survival of mesenchymal procursor cells (MPC)
08/24/2011	EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using
08/24/2011	EP2360152A1 Two types of crystalline of pinocembrin: a and b, their preparation and their use for manufacture of pharmaceutical compositions
08/24/2011	EP2359861A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
08/24/2011	EP2359855A2 Methods of administering anti-TNFalpha antibodies
08/24/2011	EP2359848A1 Peptide-based passive immunization therapy for treatment of atherosclerosis
08/24/2011	EP2359842A1 Netrin-related compositions and uses
08/24/2011	EP2359831A2 Therapeutic applications of pro-apoptotic benzodiazepines
08/24/2011	EP2359823A1 Adhesive pharmaceutical preparation containing bisoprolol
08/24/2011	EP2358877A2 Inhibition of vegf-a secretion, angiogenesis and/or neoangiogenesis by sina mediated knockdown of vegf-c and rhoa
08/24/2011	EP2358714A1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
08/24/2011	EP2358707A2 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders
08/24/2011	EP2358704A1 7-azaspiro [3.5]nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
08/24/2011	EP2358694A1 Rocaglaol derivatives as cardioprotectant agents and as antineoplastic agents
08/24/2011	EP2358692A1 Cysteine protease inhibitors
08/24/2011	EP2358382A2 NOVEL USES OF VEGFxxxB
08/24/2011	EP2358370A2 Treatment of proteinopathies using a farnesyl transferase inhibitor

1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 1595